Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
6(38%)
Results Posted
14%(1 trials)
Terminated
1(6%)

Phase Distribution

Ph not_applicable
6
38%
Ph phase_1
1
6%
Ph phase_3
1
6%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 3Large-scale testing
1(12.5%)
N/ANon-phased studies
6(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

6

trials recruiting

Total Trials

16

all time

Status Distribution
Active(7)
Completed(7)
Terminated(1)
Other(1)

Detailed Status

Completed7
Recruiting5
Active, not recruiting1
Not yet recruiting1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
6
Success Rate
87.5%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (12.5%)
Phase 31 (12.5%)
N/A6 (75.0%)

Trials by Status

active_not_recruiting16%
not_yet_recruiting16%
recruiting531%
completed744%
terminated16%
unknown16%

Recent Activity

6 active trials
Showing 5 of 16
recruiting

Anatomical-Clinical Base of Adenocarcinoma Pancreatic

NCT06128343
completed

Study During Pregnancy of Expression of miRNAs in RA or SLE

NCT02350491
completed

COVID-19: Human Epidemiology and Response to SARS-CoV-2

NCT04375761
completed

Immunome Project Consortium for Autoinflammatory Disorders

NCT03919110
active_not_recruiting

Biological and Clinical Database for Pancreatic Adenocarcinoma

NCT02818829
View all 16 trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT06128343

Anatomical-Clinical Base of Adenocarcinoma Pancreatic

Recruiting
NCT02350491

Study During Pregnancy of Expression of miRNAs in RA or SLE

Completed
NCT04375761

COVID-19: Human Epidemiology and Response to SARS-CoV-2

Completed
NCT03919110

Immunome Project Consortium for Autoinflammatory Disorders

Completed
NCT02818829

Biological and Clinical Database for Pancreatic Adenocarcinoma

Active Not Recruiting
NCT06256393

Inflammatory Bowel Disease Cohort in Nantes

Recruiting
NCT05315583Not Applicable

Neutralizing Power of Anti-SARS-CoV-2 (Anti-COVID-19) Serum Antibodies

Terminated
NCT06393764

Cancer-related Venous Thromboembolic Disease - Cohort Study

Not Yet Recruiting
NCT06407128Not Applicable

Valvular Microbiota and Valvulopathy

Recruiting
NCT04265742Not Applicable

Microbiota and Bone Fragility:Study of the Relation Between Gut Microbiota and Bone Microarchitecture

Completed
NCT04837339Not Applicable

Diagnostic and Prognostic Biomarkers of Transplant Dysfunction in the Context of Lung Transplantation

Recruiting
NCT04355234Not Applicable

Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns

Completed
NCT04917705Not Applicable

Search for Diagnostic and Prognostic Biomarkers in Systemic Sclerosis and Inflammatory Myopathies

Recruiting
NCT04070599Phase 3

Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura.

Completed
NCT01952275

Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases

Unknown
NCT01319435Phase 1

TINN Pharmacokinetics (PK) Study Treat Infections iN Neonates

Completed

All 16 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
16